FGF Signaling: Understanding Function and Devising Therapeutic Tools

Fibroblast Growth Factor (FGF) singling is an evolutionary conserved cell-to-cell communication system that regulates nearly every aspect of embryonic development, as well as adult tissue homeostasis, tissue repair and physiology. Accordingly, aberrant FGF signaling is the cause of a variety of developmental disorders, metabolic dysfunction, age-related diseases and cancer. This conference will bring together academic scientists, clinicians and industry leaders with a common interest in FGF biology to share innovations that are impacting the field. The meeting's sessions will span a range of topics to reflect the diverse biological functions of FGF signaling and its downstream molecular effectors. These topics include embryonic development and organogenesis, musculoskeletal biology, neurobiology, endocrinology, cancer biology, molecular signaling and structural biology. Each session will entertain presentations by both renowned leaders and colleagues new to the FGF field with particular emphasis on balanced gender and geographical representation. Peer reviewed abstracts will also be considered for platform presentations. In addition to the main scientific program, ample time will be devoted to networking sessions to maximize interaction and facilitate collaborations between the meeting participants. Altogether, the meeting provides a unique opportunity to integrate a wide-range of perspectives on FGF biology in relation to human health and disease, with a view to understanding disease mechanisms and devising new therapeutic tools.

Applications will be accepted for this conference through April 24, 2022.